arrow
M

Michael M. Madani

university of texas system
H指数:43
被引数:8,472

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Safety and Immediate Efficacy of Pulmonary Thromboendarterectomy for Chronic Thromboembolic Disease

肺血栓内膜切除術治疗慢性血栓性肺栓塞的安全性与即刻疗效

2026-03-010
PRE
Results of the MACiTEPH study of macitentan for the treatment of inoperable or persistent/recurrent chronic thromboembolic pulmonary hypertension

MACiTEPH研究的麦卡替尼治疗不可手术或持续/复发性慢性血栓栓塞性肺动脉高压的结果

2025-11-240
PRE
Long-term effects of medical treatment in patients with chronic thromboembolic pulmonary hypertension
2025-11-030
PRE
Increasing Colon Cancer Screening Among Previously Reluctant Populations: Importance of Tailored Messaging

提高先前不愿参与人群的结直肠癌筛查率:定制化信息的重要性

2025-10-010
PRE
RESULTS OF CHRONIC THROMBOEMBOLIC PULMONARY DISEASE PATIENTS WHO ARE DEEMED CANDIDATES FOR EITHER PULMONARY THROMBOENDARTERECTOMY OR BALLOON PULMONARY ANGIOPLASTY: INITIAL EXPERIENCE AT A SINGLE HIGH-VOLUME CENTER

慢性血栓栓塞性肺疾病患者的治疗效果:这些患者被认为适合接受肺血栓内膜剥脱术或球囊肺动脉成形术,报告单中心高容量中心的初步经验。

2025-07-110
PRE
TAPSE/PASP RATIO CORRELATES WITH PREOPERATIVE HEMODYNAMICS BUT NOT POSTOPERATIVE HEMODYNAMICS IN CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION PATIENTS UNDERGOING PULMONARY THROMBOENDARTERECTOMY

TAPSE/PASP比率与接受肺血栓内膜剥脱术的慢性血栓栓塞性肺动脉高压患者的术前血流动力学相关,但与术后血流动力学无关。

2025-07-110
PRE
Management of chronic thromboembolic pulmonary hypertension

慢性血栓栓塞性肺动脉高压的管理

2025-07-110
PRE
Worldwide CTEPH Registry: Long-Term Outcomes With Pulmonary Endarterectomy, Balloon Pulmonary Angioplasty, and Medical Therapy
2024-10-220
PRE
Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1) results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study
2024-04-018
PRE